Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAPDH | P04406 | 1/20 | 0.36 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | AGXT | P21549 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1782936 | 0.79 | CTBP2 (0.38) | CTBP2ALDH1A1RAB9AAGXTL3MBTL1 | |
| SCHEMBL1782938 | 0.79 | CTBP2 (0.38) | CTBP2ALDH1A1RAB9AAGXTL3MBTL1 | |
| SCHEMBL9064346 | 0.74 | AGXT (0.43) | CTBP2ALDH1A1RAB9AFAAHMGLL | |
| SCHEMBL6245981 | 0.74 | AGXT (0.43) | CTBP2ALDH1A1RAB9AFAAHMGLL | |
| SCHEMBL13886153 | 0.69 | CTBP2 (0.39) | CTBP2ALDH1A1RAB9AFAAHMGLL | |
| SCHEMBL4226247 | 0.67 | IDO1 (0.48) | CTBP2ALDH1A1RAB9AFAAHMGLL | |
| SCHEMBL21534728 | 0.67 | MEN1 (0.41) | CTBP2RAB9ASMN1; SMN2AGXTL3MBTL1 | |
| SCHEMBL25392436 | 0.65 | ALDH1A1 (0.39) | CTBP2ALDH1A1RAB9AFAAHMGLL | |
| SCHEMBL25392432 | 0.65 | ALDH1A1 (0.39) | CTBP2ALDH1A1RAB9AFAAHMGLL | |
| SCHEMBL25394509 | 0.65 | ALDH1A1 (0.39) | CTBP2ALDH1A1RAB9AFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809567-B2 | Method for producing silylenol ethers | KYOTO UNIVERSITY (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20130053567-A1 | METHOD FOR PRODUCING SILYLENOL ETHERS | KYOTO UNIVERSITY (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053567-A1 | METHOD FOR PRODUCING SILYLENOL ETHERS | AKR7A2, MSMO1, CYP2E1 | GAPDH 116/4885CTBP2 2783/4885ALDH1A1 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.